Replies to post #11289 on DNAprint Genomics (DNAG)

[DougS.]

frog, there was a comment that Tony made in the TWST interview that DNAP would "acquire" a drug pipeline. There have also been a few comments that they plan on being pharmaceutical company. So I'm starting from the notion that it will not be a service based deal.

Also, the type of deal that CMIH was after was money up front for the R&D ($250,000 or thereabouts) plus royalties (to DNAP) from any eventual products. This was part of DNAP's now defunct partner early, partner often philosophy. It was in essence, a no-risk proposition from DNAP's standpoint. Were DNAP to go this route they would have no need for Jolla Cove.

So how does DNAP acquire a drug pipeline that will someday be worth something yet does not cost more than they can afford???? Got me. I dunno.